Navigation Links
M*Modal Announces Fourth Quarter Earnings Release and Conference Call Dates
Date:2/16/2012

FRANKLIN, Tenn., Feb. 16, 2012 /PRNewswire/ -- MModal Inc. (NASDAQ/GS: MODL), a leading provider of clinical narrative capture services, Speech and Language Understanding technology and clinical documentation workflow, today announced details for the release of its fourth quarter and year ended December 31, 2011. 

M*Modal plans to issue its earnings release for fourth quarter fiscal 2011 after the market closes on Wednesday, March 7, 2012, and will host a conference call on Thursday, March 8, 2012, at 8:30 a.m. ET to discuss its fourth quarter results.  The number to call for this interactive teleconference is (212) 231-2900. A replay of the conference call will be available through Thursday, March 15, 2012, by dialing (402) 977-9140 and entering the confirmation number, 21576972.

The live broadcast of M*Modal's quarterly conference call will be available online at the Company's website, www.mmodal.com, under the Investors section and Events & Presentations, on Thursday, March 8, 2012, beginning at 8:30 a.m. ET.  The online replay will follow shortly after the call and continue for approximately one year. 

About M*Modal

M*Modal is a leading provider of clinical narrative capture services, Speech and Language Understanding technology and clinical documentation workflow. M*Modal's enterprise solutions -- including mobile voice capture devices, speech recognition, Natural Language Understanding, Web-based workflow platforms and global network of medical editors -- help healthcare facilities facilitate adoption of electronic health records (EHRs), improve patient care, increase physician satisfaction and lower operational costs. For more information, please visit www.mmodal.com.


'/>"/>
SOURCE M*Modal
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Precyse Solutions and M*Modal Announce Breakthrough CAC Solution
2. MedQuist and M*Modal Demonstrating End-to-End Solutions for Bringing Interactive Collaborative Intelligence to Clinical Documents at 83rd AHIMA Convention and Exhibition
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/15/2017)... PHILADELPHIA , May 15, 2017 Enterin Inc., ... and developing novel compounds to treat Parkinson,s disease ... The study is a Phase 1/2a randomized, controlled, multicenter study ... sites. It will enroll 50 patients over a 9-to-12-month period. ... doses in 10 patients with PD. Participating sites include ...
(Date:5/10/2017)... , May 10, 2017 Global Health Intelligence ... Latin America , published its 2017 ranking of ... is based on extensive data analysis from GHI,s hospitals ... hospitals database for the region. The GHI database covers 86% ... offering more than 130 data points for each institution in ...
(Date:5/9/2017)... 2017 Zimmer Biomet Holdings, Inc. (NYSE and ... announced it has earned a spot on Forbes, ... Company was ranked among 500 U.S. employers as well ... Equipment and Services. The annual Forbes ... independent survey of over 30,000 employees across 25 industries. ...
Breaking Medicine Technology:
(Date:5/23/2017)... Beach, CA (PRWEB) , ... May 23, 2017 ... ... Certified Facial Plastic and Reconstructive Surgeon Dr. Kevin Sadati, is pleased to announce ... interested in building collagen and elastin in their face, neck, and body through ...
(Date:5/23/2017)... ... 2017 , ... New patients from Charleston, SC, are now welcome to receive ... Pleasant, SC, with or without a referral. A full mouth reconstruction can transform the ... in Charleston, SC. Those who suffer from gum disease, misaligned teeth or jaw ...
(Date:5/23/2017)... ... May 23, 2017 , ... Patients in need of a ... practice to schedule an appointment, with or without a referral. Dr. Cotey is a ... to pediatric patients as a healthy alternative to a tooth extraction. , When a ...
(Date:5/22/2017)... PA (PRWEB) , ... May 22, 2017 , ... An ... to write with a pen. "My wife’s hand was damaged in a firework accident, ... something that helps people with manual problems." , He then designed and created a ...
(Date:5/22/2017)... ... 22, 2017 , ... OSF Ventures, the corporate investment arm ... early stage company in San Francisco that has developed software to individualize treatment ... Fund acted as the lead investor in the round. , Medicine is ...
Breaking Medicine News(10 mins):